BROOKS.NS Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (14 May 2024 @ 05:05):

Brooks Laboratories Limited manufactures and sells pharmaceuticals on contract basis in India and internationally. It offers carbapenem drugs; tablets; dry syrup; liquid and dry power injections; and eye and ear drop...

Stats
Today's Volume	40 178.00
Average Volume	35 606.00
Market Cap	2.60B
EPS	INR0 ( 2024-01-30 )
Next earnings date	( INR0 ) 2024-05-26
Last Dividend	INR0 ( N/A )
Next Dividend	INR0 ( N/A )
P/E	-10.40
ATR14	INR0.633 (0.64%)

Volume Correlation

Long: -0.01 (neutral)

Short: 0.00 (neutral)

Signal:(59.79) Neutral

Brooks Laboratories Correlation

10 Most Positive Correlations
OSIAHYPER.NS	0.959
GILLETTE.NS	0.954
SUULD.NS	0.954
LIBAS.NS	0.946
ALPSINDUS.NS	0.943
TATVA.NS	0.941
BUTTERFLY.NS	0.94
SINTEX.NS	0.94
INDLMETER.NS	0.939
DIAMONDYD.NS	0.939

10 Most Negative Correlations
MUKANDENGG.NS	-0.929
FINCABLES.NS	-0.925
JMCPROJECT.NS	-0.924
GEEKAYWIRE.NS	-0.919
SONATSOFTW.NS	-0.915
CLSEL.NS	-0.914
CIGNITITEC.NS	-0.913
KIRLFER.NS	-0.911
GFSTEELS.NS	-0.911
JSLHISAR.NS	-0.91

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Brooks Laboratories Correlation - Currency/Commodity

-0.54
( weak negative )

-0.31
( neutral )

-0.30
( neutral )

-0.32
( neutral )

-0.40
( neutral )

0.59
( weak )

Brooks Laboratories Financials

Annual	2022
Revenue:	INR632.05M
Gross Profit:	INR126.02M (19.94 %)
EPS:	INR-8.38

FY	2022
Revenue:	INR632.05M
Gross Profit:	INR126.02M (19.94 %)
EPS:	INR-8.38

FY	2022
Revenue:	INR900.93M
Gross Profit:	INR142.95M (15.87 %)
EPS:	INR-7.82

FY	2021
Revenue:	INR770.68M
Gross Profit:	INR218.28M (28.32 %)
EPS:	INR-7.84

Financial Reports:

No articles found.

Brooks Laboratories